Get the Stockscreener App
339.86
1.10%
3.69
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $339.86, with a volume of 660.84K.
It is up +1.10% in the last 24 hours and up +5.13% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$336.17
Open:
$342.7
24h Volume:
660.84K
Relative Volume:
0.60
Market Cap:
$64.85B
Revenue:
$328.68B
Net Income/Loss:
$2.55B
P/E Ratio:
26.07
EPS:
13.0349
Net Cash Flow:
$1.56B
1W Performance:
+5.76%
1M Performance:
+5.13%
6M Performance:
+7.02%
1Y Performance:
+6.34%
1-Day Range:
$339.44
$345.46
1-Week Range:
$318.79
$336.33
52-Week Range:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
339.86 | 64.85B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
992.91 | 115.76B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
251.07 | 58.14B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
87.03 | 9.70B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.3484 | 1.16B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-26 | Initiated | RBC Capital Mkts | Sector Perform |
| Apr-28-26 | Initiated | William Blair | Mkt Perform |
| Jan-29-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-22-26 | Upgrade | Jefferies | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora stock trades at EUR 291.90 with USD 63.3 billion value - ad-hoc-news.de
XS307124629 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR) Has Investors Asking A Bigger Question - Simply Wall Street
Cencora appointed Robert Sanchez as analysts cite USD 372.07 target for Cencora stock - ad-hoc-news.de
US03073EBF16 Bond Profile: Coupon and Redemption - TradingView
ABC4571977 Bond Profile: Coupon and Redemption - TradingView
Cencora, Inc. (COR) Options Chain - Yahoo! Finance Canada
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Cencora Inc (1COR.MI) Q3 FY2026 earnings call transcript - Yahoo Finance
ABC4213751 Bond Profile: Coupon and Redemption - TradingView
COR Maintained by Cencora -- Price Target Raised to $388 - GuruFocus
Form 4 Cencora Inc For: 6 October By Investing.com - Investing.com Nigeria
ABC6310083 Bond Profile: Coupon and Redemption - TradingView
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow (NYSE:COR) - Seeking Alpha
Cencora Inc (COR) Insider Sale: SVP & Chief Accounting Officer L - GuruFocus
A 275-share stock grant for Cencora (COR) director Robert E. Sanchez vests in one year. - Stock Titan
Cencora Inc. R (ABG.MU) Q3 FY2026 earnings call transcript - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Under a trading plan, Cencora (COR) accounting chief sells 986 shares at $303.18 each. - Stock Titan
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release - marketscreener.com
Cencora Adds Ryder Veteran to Board as Logistics Focus Grows - MyChesCo
ABC6310082 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR) Adds Robert E. Sanchez To Its Board, Is The Stock Still Cheap? - Simply Wall Street
ABC5953320 Bond Profile: Coupon and Redemption - TradingView
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release - Yahoo Finance
Cencora Inc (COR) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 80/100 - GuruFocus
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
A revocable trust holds 197 Cencora (COR) shares for director Robert E. Sanchez. - stocktitan.net
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ABC5953643 Bond Profile: Coupon and Redemption - TradingView
Cencora stock pre-market at EUR 54.84: plus 0.49 percent - AD HOC NEWS
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
ETFs Investing in Cencora, Inc. Stocks - TradingView
Cencora elects Ryder executive Sanchez to board of directors - Pennsylvania Business Report -
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today - Benzinga
Cencora stock last trades at USD 305.26 on September 28, 2026 - AD HOC NEWS
Cencora Inc Lobbyists, 2014 - OpenSecrets
Cencora Inc Agencies, 2024 - OpenSecrets
Form 8K Cencora Inc For: 25 September By Investing.com - Investing.com Nigeria
Cencora Elects Former Ryder CEO Robert Sanchez to Board - citybiz
Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026 - marketscreener.com
Robert E. Sanchez appointed to Cencora board effective Oct 1, 2026 - TradingView
Cencora appoints former Ryder CEO to board of directors - Investing.com
Cencora Elects Ryder Systems' Robert Sanchez to Board - Yahoo Finance
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cencora Inc Stock (COR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GREENBERG LON R | Director |
Sep 16 '26 |
Sale |
321.30 |
1,280 |
411,264 |
17,128 |
| Lon Greenberg | Director |
Sep 16 '26 |
Proposed Sale |
321.31 |
1,280 |
411,282 |
0 |
| Battaglia Silvana | Former Officer |
Sep 11 '26 |
Proposed Sale |
325.00 |
1,324 |
430,300 |
0 |
| Cleary James F | Former Officer |
Sep 04 '26 |
Proposed Sale |
335.17 |
10,000 |
3,351,656 |
0 |
| Krikorian Lazarus | SVP & Chief Accounting Officer |
Sep 01 '26 |
Sale |
325.97 |
985 |
321,080 |
16,169 |
| Battaglia Silvana | Former Officer |
Sep 01 '26 |
Proposed Sale |
330.00 |
6,593 |
2,175,690 |
0 |
| Campbell Elizabeth S | Executive Vice President |
Aug 24 '26 |
Sale |
324.12 |
11,300 |
3,662,663 |
19,455 |
| Campbell Elizabeth S | Officer |
Aug 24 '26 |
Proposed Sale |
324.10 |
11,301 |
3,662,663 |
0 |
| Cleary James F | Officer |
Aug 06 '26 |
Proposed Sale |
316.65 |
20,000 |
6,333,096 |
0 |
| Tyler Lauren M | Director |
Jun 22 '26 |
Buy |
270.23 |
550 |
148,626 |
4,359 |
1.34%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):